References
Frampton JE, Faulds D. PharmacoEconomics 4: 366–395, 1993
Drugs Ther Perspect 1: 4–6, 26 Apr 1993
Drugs Ther Perspect 3: 1–5, 18 Apr 1994
Drugs Ther Perspect 1: 6–7, 26 Apr 1993
Hayes JM. J Urol 149: 437–448, 1993
Stiller CR, Opelz G. Transplant Proc 23: 36–40, 1991
Evans RW, et al. Transplantation 55: 1297–1305, 1993
Simmons RG, et al. Transplantation 45: 415–421, 1988
Canafax DM, et al. Transplant Proc 25: 1692–1693, 1993
Johnson CP, et al. Transplant Proc 25: 585–586, 1993
Simon DG. Med Decis Making 6: 199–207, 1986
Gault MH, et al. Nephron 65: 583–586, 1993
Dandavino R, et al. Transplant Proc 23: 985–986, 1991
Kovarik JM, et al. J Pharm Sci 83: 444–446, 1994
Patton PR, et al. Transplantation 57: 889–892, 1994
Gueco IP, et al. Transplant Proc 24: 1709–1714, 1992
Kasiske BL, et al. JAMA 269: 395–400, 1993
Opelz G. Transplant Proc 25: 1289–1290, 1993
First MR, et al. Transplant Proc 25: 591–594, 1993
Bock HA, et al. Transplantation 57: 1484–1489, 1994
Almond PS, et al. Transplantation 55: 752–757, 1993
Suthanthiran M, et al. Transplantation 55: 1008–1013, 1993
Barry JM. Drugs 44: 554–566, 1992
Opelz G. Transplant Proc 20 (Suppl. 8): 31–36, 1988
Aswad S, et al. Transplant Proc 25: 3069–3070, 1993
Rights and permissions
About this article
Cite this article
Cyclosporin in renal transplantation: pharmacoeconomic data support clinical practice but many questions remain. Drugs Ther. Perspect 4, 1–4 (1994). https://doi.org/10.2165/00042310-199404020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199404020-00001